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High-throughput genomic methods 
generate huge amounts data 
that pose challenges for analysis 
and interpretation, requiring 
bioinformatic methods. In this thesis, 
to study molecular mechanisms 
of saccular intracranial aneurysm 
(sIA) disease, two complementary 
approaches utilizing high-throughput 
genomics and bioinformatics were 
applied. Additionally, a bioinformatic 
method and software was developed. 
Candidate genes and pathways were 
identified, which can serve as a basis 
for future research aiming to novel 
diagnostics, preventions, or therapies 
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Figure 1. Illustration of the block-like structure of the human genome caused by linkage 
disequilibrium. A) Typical variation in 18 individuals. Six correlating variants on the left of the 
recombination hotspot form three different haplotypes (out of 64 possible haplotypes) as 
indicated by different colors. Recombination breaks the correlation, and the next six correlating 
variants form two different haplotypes. B) Regions depicted in A are scattered throughout the 
chromosomes forming LD blocks of different sizes. The correlations shown in the chromosome 
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Category Count 
Length (basepairs) 3,323,950,079 
Coding genes 20,774 
Non coding genes 22,493 
Pseudogenes 14,145 
Gene transcripts 194,846 
SNPs, indels, somatic mutations 54,965,377 









A change of one nucleotide in DNA. 
Chromosomal 
abnormality 
Insertion, deletion, translocation or reversal of a large (> 3Mb) parts 
of a chromosome. 
Copy number variation 
(CNV) 
A repetition of large (1kb - 3Mb) part of genome zero (deletion) or 
more times. 
Interspersed element A repeating sequence of DNA, a remnant from viral genome. Some 
repeats contain sequence encoding viral machinery proteins required 
to copy and move the sequence. 
Simple repeat A variable number repetition of a few nucleotide sequence. 
Insertion or deletion 
(INDEL) 
A change of addition or removal of one or more nucleotides. 
Structural variant (SV) 1 kb and larger in size and can include inversions and balanced 
translocations or large insertions or deletions 
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Figure 3. Genotype imputation. A) Illustration of the gain in power and fine-mapping provided 
by imputation. B) Schematic illustration of the genotype imputation process modified from the 
following article (Marchini & Howie 2010). See text for explanation. 
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2.2 THE HUMAN TRANSCRIPTOME 
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Figure 4.  Illustration of a gene promoter and regulation. Chromatin consists of  DNA packaged 
into histones. This packaging must be unwound for the transcriptional machinery to have access 
to the transcription start site (TSS) in the core promoter. Transcription factors bind to their 
specific transcription factor binding sites (TFBS) near the TSS (proximal region) or further away 
(enhancer) and can influence the transcriptional efficiency. Adapted from (Maston et al. 2006; 
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Figure 5. A) Drawing of a saccular intracranial aneurysm at a typical location in the Circle of 
Willis at the base of the brain (modified from www.nebraskamed.org). B) Photograph of a 
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Figure 6. Schematic diagram of intracranial extracerebral artery wall structure. Adapted from 
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Table 3. Replicated genetic variants/loci linked to sIA disease 
RAF: Risk allele frequency; LNK: linkage; MEND: Mendelian disease associated with sIA disease; ADPKD: 
Autosomal Dominant Polycystic Kidney Disease; * European populations in 1000 Genomes Project 
 
Locus Gene RAF Study 
type 
Effect size Reference 
4q31.23 EDNRA 85%* GWAS OR 1.22 (95%-CI  
1.14–1.31) 
(Yasuno et al. 2011) 
8q12.1 SOX17 83%* GWAS 1.28 (1.20–1.38) (Yasuno et al. 2010) 
9p21.3 CDKN2A/ 
CDKN2B 
58%* GWAS 1.32 (1.25–1.39) (Yasuno et al. 2010) 
10q24.32 CNNM2 91%* GWAS 1.29 (1.19–1.40) (Yasuno et al. 2010) 
13q13.1 KL, 
STARD13 
23%* GWAS 1.20 (1.13–1.28) (Yasuno et al. 2010) 












LNK - (Nahed et al. 2005; Ruigrok 











LNK -  (Onda et al. 2001; Farnham 
et al. 2004) 
19q13.3 Many.  Likely 
rare 
LNK - (Olson et al. 2002; Yamada et 
al. 2004; van der Voet et al. 
2004; Mineharu et al. 2007) 
Xp22 Many. Likely 
rare 
LNK - (Yamada et al. 2004; Ruigrok 
et al. 2008) 
16p13.3 PKD1 Rare MEND Prevalence of sIA 
is 6.9 higher in 
ADPKD patients 
than in general 
population. 
(Vlak et al. 2011) 
4q22.1 
 
PKD2 Rare MEND Prevalence of sIA 
is 6.9 higher in 
ADPKD patients 
than in general 
population. 
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Table 4. Whole-genome gene expression profiling studies of human saccular intracranial 
aneurysm tissue. 
Cases Controls Genes ↑  Genes ↓ Array Ref. 





263 258 Agilent Human 
1A(v2)  
(Krischek et al. 2008) 
6 RA 4 UAs 2* 0 Agilent Human 
1A(v2)  
(Krischek et al. 2008) 







172 154 Illumina Human 
WG6-v2 
(Shi et al. 2009b) 
3 RAs 3 UAs 0 0 Illumina Human 
WG6-v2 
(Shi et al. 2009b) 
3 UAs 3 STAs 164 996 Affymetrix 
HU133 Plus 2.0 
 
(Li et al. 2009) 
8 RAs and 6 
UAs 
5 MMA 8  123 Affymetrix 
GeneChip 
Human Gene ST 
1.0 
(Pera et al. 2010) 
8 RAs 6 UAs 1 31 Affymetrix 
GeneChip 
Human Gene ST 
1.0 
(Pera et al. 2010) 
12 RAs 10 UAs 10  4 Affymetrix  
U133A 
 









22 8 Affymetrix  
U133A 
 
(Marchese et al. 2010) 
RA: Ruptured saccular intracranial aneurysm; UA: Unruptured saccular intracranial aneurysm; STA: 
Superficial temporal artery; AVM Arteriovenous malformation; Middle meningeal Artery; * Did not specify 
if the genes were upregulated or downregulated. 
 
 &
2.5 CHALLENGES AND BIOINFORMATIC SOLUTIONS FOR 
INTERPRETATION OF RESULTS FROM HIGH THROUGHPUT 
ANALYSES 
(1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Figure 7. Illustration of a Gene Ontology tree. Annotations can be depicted as directed acyclic 
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Rupture (h)  
Microarray qRT-PCR 
1. F 60 MCA -  + - 
2. F 64 ICA -  + - 
3. M 47 MCA -  + - 
4. F 37 MCA -  + - 
5. M 42 MCA -  + + 
6. F 62 MCA -  + + 
7. M 56 PCoA -  + + 
8. F 65 MCA -  + + 
9. F 56 MCA -  - + 
10. M 42 MCA -  - + 
11. F 59 MCA -  - + 
12. F 54 MCA + 16 + - 
13. F 46 ACoA + 96 + - 
14. M 58 MCA + 24 + + 
15. F 71 ACoA + 216 + + 
16. F 52 ICA + 168 + + 
17. F 32 MCA + 3 + + 
18. F 83 MCA + 2.6 + + 
19 M 73 MCA + 3.6 + + 
 	
20. F 69 MCA + 6.7 + + 
21. F 53 MCA + N.A. + + 
22. M 70 MCA + 14 + + 
23. F 57 PCoA + 6.4 - + 
24. F 58 MCA + 12 - + 
25. F 44 MCA + 11 - + 
26. F 53 MCA + 24 - + 
27. F 47 ACoA + 5.2 - + 
28. M 41 ACoA + 9.1 - + 
29. F 62 PCoA + 72 - + 
F = female; M = male; MCA = middle cerebral artery; PCoA = posterior communicating artery;  
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Figure 9. Comparison of expression of 5 selected genes in 16 ruptured and 7 unruptured 
saccular intracranial aneurysm (sIA) wall samples by quantitative real-time polymerase chain 
reaction (RT-PCR). Gene expression ratios in the RT-PCR study and in the microarray study (in 
parentheses; 11 ruptured and 8 unruptured sIA wall samples) are presented. The y-axis 
indicates in arbitrary units the expression level of each gene normalized by ribosomal RNA 
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Figure 10. Ten ruptured saccular intracranial aneurysm (sIA) wall samples arranged according 
to the expression levels of all 17 788 genes studied (see Materials and Methods). The 5 samples 
resected < 24 hours after the rupture are denoted by E (early), and the 5 samples resected >= 
24 hours are denoted by L (late). The time elapsed in hours from rupture to the resection is 
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Table 6. Biological processes differentially expressed in ruptured vs. unruptured sIA wall 
samples.  
UPREGULATED GENES 
Gene Ontology (GO) 







chemotaxis  GO:0006935 2.60E-14 5.66E-11 7 30 125 
immune response  GO:0006955 5.70E-14 6.26E-11 4 49 333 
response to external 
stimulus  GO:0009605 1.00E-13 7.41E-11 3 74 651 
inflammatory response  GO:0006954 1.40E-13 7.52E-11 4.2 46 296 
locomotory behavior  GO:0007626 1.50E-11 6.46E-09 4.5 35 208 
response to stress  GO:0006950 3.60E-09 1.31E-06 2.1 99 1224 
response to other 
organism  GO:0051707 4.70E-08 1.49E-05 5.7 18 87 
positive regulation of 
tumor necrosis factor 
production  GO:0032760 5.80E-08 1.60E-05 
12
7 6 7 
locomotion  GO:0040011 1.30E-07 3.18E-05 4.7 20 114 
cytokine production  GO:0001816 2.50E-05 5.49E-03 3.8 16 108 
phosphate metabolic 
process  GO:0006796 5.30E-05 1.06E-02 1.8 66 893 
positive regulation of 
interleukin-6 
production  GO:0032755 5.90E-05 1.08E-02 42 4 6 
regulation of cell 
proliferation  GO:0042127 1.80E-04 3.10E-02 1.9 44 550 
intracellular lipid 
transport  GO:0032365 2.60E-04 3.55E-02 21 4 8 
neutrophil chemotaxis  GO:0030593 2.70E-04 3.55E-02 12 5 14 
regulated secretory 
pathway  GO:0045055 2.70E-04 3.55E-02 12 5 14 
Protein amino acid 
phosphorylation  GO:0006468 2.70E-04 3.55E-02 1.8 47 613 
regulation of cytokine 





biosynthetic process  GO:0009168 3.90E-04 4.55E-02 11 5 15 
KEGG biological 
process KEGG ID P value  FDR OR Count Size 
Cytokine-cytokine 
receptor interaction 4060 8.50E-06 7.82E-04 2.7 31 245 
toll-like receptor 
signaling pathway  4620 1.10E-05 7.82E-04 4 17 94 
hematopoietic cell 
lineage 4640 1.70E-05 8.10E-04 4.3 15 78 
epithelial cell signaling 
in Helicobacter pylori 
infection  5120 5.80E-05 2.03E-03 4.3 13 67 
fructose and mannose 
metabolism 51 3.30E-04 8.81E-03 5.6 8 33 
leukocyte 
transendothelial 
migration 4670 3.80E-04 8.81E-03 3 16 112 
Gene Ontology 
cellular 
compartment GO ID P value FDR OR Count Size 
membrane  GO:0016020 2.50E-07 5.30E-05 1.5 325 6028 
vacuole  GO:0005773 3.30E-07 5.30E-05 3.5 26 193 
Arp2/3 protein 
complex  GO:0005885 9.30E-07 9.80E-05 
11
0 5 6 
cytoplasm  GO:0005737 5.10E-05 3.80E-03 1.4 329 6428 
integral to plasma 
membrane  GO:0005887 6.00E-05 3.80E-03 1.7 72 1053 
NADPH oxidase 
complex  GO:0043020 2.20E-04 1.18E-02 22 4 8 
extracellular space  GO:0005615 3.20E-04 1.43E-02 1.9 39 497 
membrane raft  GO:0045121 5.60E-04 2.23E-02 3.9 10 66 
lysosome  GO:0005764 8.10E-04 2.85E-02 3.1 13 108 
cytosol  GO:0005829 1.30E-03 4.09E-02 1.6 55 827 
Proton-transporting V-
type ATPase, V0 




Gene Ontology  
cellular 
compartment GO ID P value  FDR OR Count Size 
nucleus  GO:0005634 1.40E-05 4.81E-03 1.5 235 4487 
intracellular part  GO:0044424 5.90E-05 1.04E-02 1.8 79 1487 
costamere  GO:0043034 9.60E-05 1.11E-02 31 4 7 
adherens junction  GO:0005912 5.90E-04 4.36E-02 3.6 11 82 
tight junction  GO:0005923 6.30E-04 4.36E-02 5.6 7 36 
* identification code; ** p-value uncorrected for multiple testing; *** false discovery rate, p-value after 
multiple testing correction (see Materials and Methods); **** number of differentially expressed genes in 
each biological category; ***** total number of genes assayed in the present study in each category. 
  














ELF1 ELF1 411  11549 1.66E-08 ETS 
PEA3 ETV4 714  21887 1.66E-07 ETS 
ETS2 ETS2 413 11968 3.64E-07 ETS 
ETS1 ETS1 728 22501 3.87E-07 ETS 
HIF1 HIF1A 304 8663 3.13E-06 - 
NFKAPPAB65 RELA 96 2232 7.99E-06 
Rel/ank
yrin 
Transcription factor name at *TRANSFAC® (www.gene-regulation.com) and ** HUGO Gene Nomenclature 
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Figure 11. Upregulated genes in selected cellular signaling pathways in a neutrophil 
granulocyte, hypothesized here to infiltrate a ruptured saccular intracranial aneurysm wall. 
Neutrophil signaling pathways are adapted from the following references (Reichel et al. 2006; 
Nizet & Johnson 2009; Rommel et al. 2007; Tanaka et al. 2003). Red boxes indicate proteins of 
the upregulated genes; white boxes indicate proteins of the nondifferentially expressed genes. 
NCF1 gene in the grey box was not included in the array. Many of the signaling pathways are 











   			 	
	 (
	  76**
$2 **4@ /%& 6T' +/T *$& $' $ 7	
  # &"""88 =
( 









  	 
	 # )
	  			 

( '%$     
   
  		 

			 
   (





































































 	 75  #
&"";8# /		
  $ 
 	 


















































	   
 
 (		











   
		 
 	 




























( 7'  # &"";I /(
 &"":I a



















































































	  		  	) = 
 
   	
		    
 		F
 	  
 	  
  	 
  





















 	   
(  	  (






	#  		 
	 
 	= (	 


 	  
		  	 









	  % (



















   	 	

 















  	 














  = (
	# 	 	 















  # &""@I %

	 D  # &""!I +
















	(	  	   





   ( 	(

 


























   	  
 ( 



































 		  % (
	# 














	9  	 
	













































































   
	      
  		 	= =























	   ( 	   
  
























































































































  # &""@8#  	















Figure 12. The flow diagram of TAFFEL analysis. From the top: the list of genes given by the 
user is annotated by GO and TF information from Ensembl (20) and cisRED (12) databases. The 
genes are clustered separately in parallel, based on GO and TF annotations (for simplicity only 
the TF clustering tree is shown). In each resulting cluster, the enrichment of both GO and TF 
annotations is determined, providing a basis for suggesting implications between the biological 
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Figure 13. TAFFEL user interface. The clustering trees represents the clustering result for the DE 
genes after 4 hours of forskolin treatment in HEK293T cells. The genes have been clustered by 
the GO terms (left) and TFs (right). The topmost box represents the whole gene set without 
clustering. Below that, each level represents clustering to two, three, or more clusters. The 
green outline indicates the cluster number selection by AIC and blue by dAIC. The clusters 
obtained from the IEA analysis with FDR p < 0.1 are highlighted with the light blue background 
on the right side of cluster box. The best intercorrelating clusters (cell morphogenesis cluster in 
the GO tree and COUP cluster in the TF tree) between the trees are connected with the bold 
line. Information at bottom shows enriched annotations (left list) and cluster genes (right list). 
Positive regulation of biosynthetic process related cluster is selected in the picture. 
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Table 8. Statistically significant clusters in up-regulated (sIA↑) and down-regulated (sIA↓) genes 
in ruptured intracranial aneurysms. CLUSTER column indicates the clustered dataset, 
annotations used for clustering (either GO or TF) and the size of the cluster, respectively. 
ANNOTATION column indicates enriched GO terms and TF annotations from TRANSFAC in each 
cluster. P and P LIST columns indicate Benjamini-Hochberg FDR corrected Fisher’s exact test p-
values for the enrichment of the annotation in the cluster and in the gene list, respectively. N 
and N LIST columns show the number of genes associated with the annotation in the cluster 
and in the gene list. 
 
CLUSTER ANNOTATION P P LIST N N LIST 
sIA ↑ 
 
GO 58 cation transport 3.8E-08 1.8E-01 17 23 
ion transport 3.8E-08 3.7E-01 18 26 
metal ion transport 1.2E-05 4.2E-01 12 16 
…     
protein amino acid 
phosphorylation 
4.5E-4 9.6E-03 16 35 
regulation of protein kinase 
activity 
1.0E-02 1.5E-01 7 12 
G-protein signaling, coupled 
to IP3 second messenger 
(phospholipase C activating) 
2.9E-02 1.6E-01 4 5 
regulation of Ras GTPase 
activity 
7E-02 1.5E-01 4 6 
MTF-1 4.8E-02 4.7E-01 13 30 
ATF-1 4.8E-02 6.5E-01 9 17 
sIA ↓ GO 22 nervous system development 1.3E-11 1.3E-02 17 32 
generation of neurons 2.1E-06 2.8E-01 8 10 
cell development 2.1E-06 2.8E-01 10 17 
…     
blood vessel morphogenesis 3.5E-04 2.8E-01 5 6 
cell migration 4.3E-04 7.2E-01 4 4 
Tal-1 3.1E-02 1.0E+00 4 5 
AR 9.4E-02 9.8E-01 6 17 
sIA ↓ GO 49 organic acid metabolic 
process 
1.3E-08 2.8E-01 13 13 
carboxylic acid metabolic 
process 
1.3E-08 2.8E-01 13 13 
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…     
lipid metabolic process 5.3E-07 4.4E-01 13 16 
   carbohydrate metabolic 
process 
2.8E-3 5.5E-01 7 9 
   amino acid metabolic process 
 
3.2E-03 5.2E-01 5 5 
 NF-1 3.7E-02 9.8E-01 14 30 
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Figure 14. Study design. The Finnish discovery and replication cohorts represent a population 
with an over two-fold increased risk of subarachnoid hemorrhage from ruptured saccular 
intracranial aneurysm (sIA-SAH). The Finnish discovery cohort was intentionally enriched with 
familial sIA patients, and 9.4M genotyped and imputed variants were studied. The loci with p < 
5E-6 were replicated in an independent and unselected Finnish sIA sample. The allele 
frequencies and effect sizes of the replicated variants in Finland were finally compared to a 
continental European population using a Dutch sample. The sIA-SAH risk is not increased in the 
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Table 11. The Finnish and Dutch study samples used in the association analysis of saccular 
intracranial aneurysm (sIA) disease.  
 
Finnish discovery Finnish replication Dutch replication 
Cases Controls Cases Controls Cases Controls 
       
N 760 2,513 858 4,048 717 3,004 
Women 443 (58%) 1,454 (58%) 532 (62%) 2,182 (54%) 492 (67%) 1,135 (38%) 
Familial sIA 300 (40%) - 51 (6%) - 100 (15%)* - 
sIA-SAH 561 (74%) - 587 (68%) - 658 (92%) - 
Mean age (yrs) 50 52 52 40 54 68 
Number of sIAs       
   mean 1.54 (1-8) - 1.46 (1-6) - 1.26 (1-7) - 
   > 2 242 (32%) - 257 (30%) - 127 (18%)** - 
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Figure 15. Regional association plots of the five identified saccular intracranial aneurysm (sIA) 
loci in the combined Finnish samples and the Dutch sample. Association p-values (–log10 scale, 
y-axis) of variants are shown according to their chromosomal positions (x-axis). Blue lines 
indicate the genetic recombination rate (cM/Mb). Figures A-C present the loci identified in the 
case vs. control analysis at 2q23.3, 5q31.3, and 6q24.2, respectively. Figure D presents the 
7p22.1 locus associated to the sIA count per patient. Figure E presents the 2q33.1 locus with 
inconclusive previous evidence. Purple rectangles indicate the most significant variant in a) the 
Finnish discovery sample and, along the dashed line, its p-values in b) the combined Finnish 
samples (META FIN) and in c) all samples (META ALL). Adjacent variants in linkage 
disequilibrium (r2; EUR populations, 1000 Genomes March 2012) to the index variant are shown 
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Table 12. Summary of common high-throughput methods in genomic studies of complex human 
diseases.  









to capture mRNA 
printed on chips 
designed based on 

































More expensive than 
microarrays, less 
mature statistical 
methods for quality 
control and analysis, 
biological 
interpretation of 
results can be 
challenging. 







designed based on 
known variations 










Detection of known 
variants only, most 
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Protein coding parts 
of genome are 
captured using 
capture kit, which is 























variants, can detect 











variants / loci 
Next generation 
















is expensive, larger 
structural variant 
detection still 
unreliable, very high 
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Table 13. Short summary of typical pathway analysis methods of high-throughput genomic 
studies. 





gene sets. Assess if some 
pre-specified gene 
annotations (e.g. biological 
functions) occur in the 
analyzed gene set more 
often than would be 
expected just by chance. 
Aids interpretation of 




huge variety of 
software available.   
Depends on the 
accuracy of 
annotations, existing 
gene annotations may 




gene set is based on 
arbitrary statistical cut-
off, huge variety of 
software available.   
Enrichment analysis Interpretation of 
differentially expressed 
gene sets. Assess if pre-
specified annotations (e.g 
pathways) occur in top or 
bottom of ranked list of 
genes more often than 
would be expected just by 
chance. 
Aids interpretation of 
gene sets by 
highlighting higher 











Depends on the 
accuracy of 
annotations, existing 
gene annotations may 
not be relevant in the 
studied 
condition/tissue, 
ignores interaction of 






gene sets. Takes into 
account the topological 
ordering of interacting 
genes in a pathway when 
Aids interpretation of 
gene sets by 
highlighting biological 
pathways, utilizes the 
topological 
information of 
Depends on the 
accuracy of pathways, 
existing pathways may 







7.2 QUEST FOR MOLECULAR PATHOMECHANISMS OF SACCULAR 
INTRACRANIAL ANEURYSM DISEASE 
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Identification of possibly 
weak but coordinated 
statistical signal among 
genes belonging to a 
common pathway. 
Helps to put the 
genetic findings in 
biological context, aid 
in discovery of 
genomic loci with 





recently developed and 
no clear consensus 
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Genomics and Bioinformatics 
Approaches in Search of 
Molecular Pathomechanisms 
of Saccular Intracranial 
Aneurysm, A Complex 
Disease
Mitja Kurki
Genomics and Bioinformatics 
Approaches in Search of Molecular 
Pathomechanisms of Saccular 
Intracranial Aneurysm, A Complex 
Disease
High-throughput genomic methods 
generate huge amounts data 
that pose challenges for analysis 
and interpretation, requiring 
bioinformatic methods. In this thesis, 
to study molecular mechanisms 
of saccular intracranial aneurysm 
(sIA) disease, two complementary 
approaches utilizing high-throughput 
genomics and bioinformatics were 
applied. Additionally, a bioinformatic 
method and software was developed. 
Candidate genes and pathways were 
identified, which can serve as a basis 
for future research aiming to novel 
diagnostics, preventions, or therapies 
of sIA disease. 
